WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, B. N.
Right arrow Articles by David, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, B. N.
Right arrow Articles by David, S.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2002, 22(15):6578-6586

Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury

Bharatkumar N. Patel, Robert J. Dunn, Suh Young Jeong, Qinzhang Zhu, Jean-Pierre Julien, and Samuel David

Centre for Research in Neuroscience, The Montreal General Hospital Research Institute and McGill University, Montreal, Quebec, Canada, H3G 1A4


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Ceruloplasmin is a ferroxidase that oxidizes toxic ferrous iron to its nontoxic ferric form. We have previously reported that a glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed in the mammalian CNS. To better understand the role of ceruloplasmin in iron homeostasis in the CNS, we generated a ceruloplasmin gene-deficient (Cp-/-) mouse. Adult Cp-/- mice showed increased iron deposition in several regions of the CNS such as the cerebellum and brainstem. Increased lipid peroxidation was also seen in some CNS regions. Cerebellar cells from neonatal Cp-/- mice were also more susceptible to oxidative stress in vitro. Cp-/- mice showed deficits in motor coordination that were associated with a loss of brainstem dopaminergic neurons. These results indicate that ceruloplasmin plays an important role in maintaining iron homeostasis in the CNS and in protecting the CNS from iron-mediated free radical injury. Therefore, the antioxidant effects of ceruloplasmin could have important implications for various neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease in which iron deposition is known to occur.

Key words: iron; neurodegeneration; free radicals; lipid peroxidation; ferroxidase; aceruloplasminemia; Parkinson's disease; oxidative stress


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Iron plays an important role in many biological processes. It is an essential cofactor for various enzymes, including ribonucleotide reductase and aconitase, and its presence in heme imparts hemoglobin the ability to transport oxygen and enables cytochrome oxidase to reduce oxygen to water. The oxidation-reduction reactions of iron are fundamental to its role as a cofactor. However, this also makes free iron highly toxic because of its ability to generate free radicals. In particular, ferrous [Fe (II)] iron can generate the highly toxic hydroxyl and superoxide free radicals in the presence of hydrogen peroxide or molecular oxygen. Consequently, iron metabolism is tightly regulated by various proteins that transport, sequester, and mobilize iron (De Silva et al., 1996).

Transferrin, the major iron-transporting protein in plasma, transports iron from sites of storage, such as the liver, to tissues using iron. The ferroxidase ceruloplasmin (Cp), which is produced by the liver and secreted into the plasma, also plays an important role in the movement of iron. By oxidizing the ferrous [Fe (II)] form of iron to the ferric [Fe (III)] form, Cp promotes iron loading onto transferrin, which only binds the ferric form of the metal (Osaki et al., 1966). In addition, Cp is an effective antioxidant, because of its ability to oxidize highly toxic ferrous iron to the relatively nontoxic ferric form and thus help prevent oxidative damage to proteins, lipids, and DNA (Gutteridge, 1992).

Ceruloplasmin is expressed by astrocytes in the brain, cerebellum, and retina and by the epithelial cells of the choroid plexus (Klomp et al., 1996; Patel and David, 1997; Patel et al., 2000). Although hepatocytes in the liver produce a secreted form of Cp found in serum that does not cross the blood-brain barrier, astrocytes express an alternatively spliced, glycosylphosphatidylinositol (GPI)-anchored form of Cp (Patel and David, 1997; Patel et al., 2000). This GPI-anchored form of Cp is the predominant form expressed in the brain (Patel et al., 2000) and is likely to play an important role in iron homeostasis and antioxidant defense in the CNS. The full-length cDNA for human GPI-Cp has been reported recently (Hellman et al., 2002).

The importance of Cp in vivo is most clearly illustrated by studies of patients with aceruloplasminemia, a hereditary deficiency of Cp caused by mutations in the Cp gene (Miyajima et al., 1987; Harris et al., 1995; Morita et al., 1995; Yoshida et al., 1995; Gitlin, 1998). Patients with this disorder have massive iron deposition in a number of organs, including the brain and liver. The iron deposition in the brain leads to neurodegeneration and neurological symptoms, such as motor incoordination and other motor deficits, between the ages of 45 and 55 years. The severe iron accumulation in these patients suggests that Cp prevents iron accumulation in vivo. Indeed, a recent study of Cp-/- mice showed that the iron that accumulates in the liver can be released when these mice are treated with ceruloplasmin (Harris et al., 1999).

We now report that increased iron accumulation and free radical injury occur in the CNS of Cp-/- mice. In addition, we present in vitro data that provide direct evidence that CNS tissue from Cp-/- mice is more susceptible to iron-mediated free radical injury. The Cp-/- mouse offers a good model for the study of the human disease aceruloplasminemia and can provide insights into the pathogenesis and secondary damage that may occur in other neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis, in which iron deposition occurs.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Generation of Cp-/- mice. To construct a gene-targeting vector, a mouse 129/Sv genomic library in Lambda Dash II (Stratagene) was screened with a probe to the first exon of the rat Cp gene (Fleming and Gitlin, 1990). The two longest positive clones, containing inserts of 11 and 12 kb, were mapped with restriction enzymes. A BglII-NheI fragment containing the first exon was replaced with a neo cassette (Promega) in the orientation opposite to that of the Cp gene to produce the targeting vector (see Fig. 1A). The linearized targeting construct was electroporated into R1 embryonic stem (ES) cells as described (Joyner, 1993).

ES cell clones resistant to G418 (Life Technologies) were selected. Genomic DNA was isolated from these clones and digested with EcoRI. Southern blot analysis was performed using a probe to the mouse genomic sequence upstream of the sequence used in the targeting construct to identify clones with a homologous recombination event. Two positive ES cell clones were microinjected into C57BL/6J blastocysts that were then implanted into pseudopregnant BALB/c mice. The resulting male chimeras were then mated with C57BL/6J females, and the resulting F1 animals were genotyped by Southern blot analysis to identify heterozygotes, which were back-crossed to C57BL/6J animals. After one or more rounds of back-crossing, the resulting heterozygous mice were mated, and the resulting mice were genotyped by Southern blot analysis or PCR and subsequently used for analysis. All protocols for mice were in accordance with the Canadian Council on Animal Care guidelines and approved by the McGill University Animal Care Committee.

Western blot analysis. Western blots were performed using serum from Cp+/+ and Cp-/- mice to determine whether Cp protein expression was absent in Cp-/- mice. Serum (0.1 µl) diluted in Tris-buffered saline was subjected to SDS-PAGE, and Western blot analysis was performed using a rabbit anti-human Cp antibody (Dako) as described previously (Patel and David, 1997).

Iron histochemistry. Mice were perfused with 0.1 M phosphate buffer, pH 7.2, followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2. Iron was detected in cryostat sections of the liver using a modified Perl's stain for iron (Smith et al., 1997). For this, tissue sections were rehydrated in deionized water and incubated with a 7% solution of potassium ferrocyanide in 3% HCl for 60 min. Sections were then rinsed and counterstained with 1% neutral red and coverslipped. Iron histochemistry on the cerebellum and brainstem was performed using an enhanced Perl's stain that is more sensitive than the one described above. For this, tissue sections were washed in PBS and then incubated in 4% potassium ferrocyanide in 4% HCl for 1 hr. After rinsing in PBS, tissue sections were incubated with unactivated diaminobenzidine (DAB) containing 1% nickel chloride for 15 min. This was followed by a 15 min incubation with activated DAB and counterstaining with neutral red. Tissue sections of wild-type and knock-out mice were picked up on the same slide to permit monitoring and detection of nonspecific staining.

Immunohistochemistry. Tyrosine hydroxylase (TH) immunohistochemistry was done to detect dopaminergic neurons in the midbrain. Cryostat sections (15-20 µm) of 4% paraformaldehyde-fixed brain from Cp+/+ and Cp-/- mice were processed for immunohistochemistry as described previously (Ousman and David, 2000). Tissue sections were incubated overnight with a polyclonal rabbit anti-TH antibody (1:200; Chemicon, Temecula, CA). Binding of the primary antibody was detected using a biotinylated secondary antibody followed by avidin-biotin complex conjugated to peroxidase and visualized as described previously (Ousman and David, 2000).

Total non-heme iron determination. Total non-heme iron (TNHI) was measured as described previously by Torrance and Bothwell (1980), with slight modifications. Briefly, tissues were removed from mice after perfusion with PBS. Tissues were dried for 48 hr at 45°C, weighed, and digested for 48 hr in 10% trichloroacetic acid/10% HCl at 65°C. Two hundred microliters of the extract were then added to 1 ml of chromogen solution (0.01% bathophenanthroline-disulfonic acid, 0.1% thioglycolic acid, 7 M sodium acetate) and incubated for 10 min, and the absorbance was measured at 535 nm. A certified iron standard from Sigma (kit 565A) was used to determine iron levels. A standard curve performed for iron concentrations between 10 and 500 µg/ml revealed a linearity of response with a slope of ~1. Samples were diluted appropriately to fall within the linear range, and a 100 µM FeCl3 solution was used as an additional internal control. TNHI values were expressed as micrograms of iron per gram of dry weight.

Lipid peroxidation assay. Lipid peroxidation was assessed using the thiobarbituric acid reactive substances (TBARS) assay that detects malondialdehyde (MDA), an end product of the peroxidation of polyunsaturated fatty acids and related esters (Bowie et al., 1997). Briefly, tissues were homogenized with 0.5% SDS in PBS, and 100 µl of the sample was incubated with 900 µl TBARS reagent (0.4% 2-thiobarbituric acid, 0.5% SDS, 10% acetic acid, pH 3.5), incubated for 60 min at 95°C, and centrifuged, and the absorbance of the supernatant was read at 532 nm. The amount of TBARS was quantified using a standard curve of MDA [malonaldehyde bis (dimethyl acetal)] and expressed as nanomoles of MDA per gram of protein.

Serum iron measurement and hematological analysis. Serum iron levels and total iron-binding capacity were determined using a kit from Sigma. Hematological parameters, such as hematocrit, hemoglobin levels, red blood cell counts, white blood cell counts, and platelet counts, were performed using an automated counter using fresh heparinized blood.

Behavioral assays. To assess motor skills, mice were put on a 3-cm-diameter rod that was covered with a thin rubber mat for grip and rotated at 20 rpm (rotary rod assay) (Steele et al., 1998). The mice were given a training period and subsequently put on the rod for a maximum duration of 3 min. The mice were allowed to rest for 2 min, and the test was repeated five more times.

To assess whether the Cp-/- mice had impaired activity levels, mice were placed in cages containing a hamster wheel that was connected to a meter (Liu et al., 1997). The total distance for the 12 hr night cycle was recorded for each mouse, and the test was performed for two additional nights. The average distance per 12 hr night cycle for each mouse was used for the data analysis.

To determine whether the Cp-/- mice had reduced muscle strength, the mice were placed on a thin metal grid attached to weights of increasing mass. After the mice had grasped the grid, they were gently raised by the base of their tails (Frey et al., 2000), and the maximum weight held by the mice for a period of 5 sec was recorded.

In vitro H2O2 toxicity assay. Dissociated cultures of the cerebellum were prepared from postnatal day 9 mice using previously described protocols (Mittal and David, 1994). Dissociations were performed using 0.25% trypsin in HBSS for 10 min at room temperature. Cells were plated into poly-L-lysine-coated 24-well tissue culture plates (Linbro) at a density of 8 × 105 cells per well and grown in DMEM containing 10% fetal bovine serum, vitamins, and penicillin/streptomycin. These cultures contain a mixture of mainly neurons and astrocytes, with the latter expressing the GPI-anchored form of Cp (Patel and David, 1997).

After 4 d in culture, the cerebellar cell cultures were washed twice with DMEM, and fresh serum-free Neurobasal Medium containing G-5 supplement, L-glutamine, vitamins, and penicillin/streptomycin (Life Technologies) was added. After 2 hr, fresh serum-free medium containing H2O2 at either 50 or 250 µM was added to the cultures in quadruplicate wells. In some experiments, the iron chelator desferrioxamine mesylate (DFO) was included at 125 µM and added immediately before the addition of H2O2. After 24 hr, cultures were washed with DMEM and incubated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide [(MTT); 0.5 mg/ml in DMEM] for 90 min (Hansen et al., 1989). The medium was then removed, and the cells were solubilized with 1 ml isopropanol/0.1N HCl. The blue color reaction in the solution was quantified with a spectrophotometer at 570 nm, and the results were normalized to control cultures not treated with H2O2.

For immunostaining, the cerebellar cells were plated on poly-L-lysine-coated 15-mm-round glass coverslips at 5 × 105 cells per coverslip. Cells were cultured and treated with 50 µM H2O2 as described above. At the termination of the experiment, cultures were fixed and permeabilized and double labeled with a monoclonal anti-neurofilament antibody, RT97, to label neurons and a rabbit polyclonal anti-glial fibrillary acidic protein antibody to label astrocytes. Primary antibodies were visualized using appropriate rhodamine- and fluorescein-conjugated secondary antibodies, and the nuclei were labeled with nuclear yellow (Hoechst S769121).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

To generate Cp-deficient mice, a targeting vector that contained a neo gene cassette flanked on either side by a 3 kb ceruloplasmin genomic sequence was used to replace a 3 kb endogenous fragment containing the first exon of the ceruloplasmin gene (Fig. 1A). This strategy eliminates both the transcription start site as well as the first exon that codes for the signal peptide, thus eliminating the possibility that a truncated protein might be produced. Southern blotting demonstrated the successful generation of Cp-/- mice and was used to genotype mice for analysis (Fig. 1B). Western blotting of the serum confirmed the absence of Cp in Cp-/- mice (Fig. 1C).



View larger version (45K):
[in this window]
[in a new window]
  		Figure 1.   Generation of Cp-/- mice. A, The targeting vector was generated by replacing the 3 kb BglII-NheI fragment containing the first exon of the Cp gene with a neo cassette. Homologous recombination of the targeting vector in ES cells leads to the generation of a 6.5 kb EcoRI fragment compared with a 11 kb wild-type fragment detected using a 1.5 kb probe upstream of the targeting vector (probe). BI, BglI; BII, BglII; EI, EcoRI; NI, NheI; PI, PstI; XI, XhoI. B, Southern blot of EcoRI-digested genomic DNA from F2 animals using the probe shown in A. C, Western blot of serum using a rabbit anti-Cp polyclonal antibody. Both Cp+/+ and Cp+/- mice contain large amounts of Cp in the serum, whereas Cp-/- mice lack Cp. D, Histological sections of the livers of 16-month-old Cp+/+ and Cp-/- mice stained for iron using Perl's stain. The sections were counterstained with neutral red. The liver from a Cp+/+ mouse (+/+) does not show staining for iron. Only the neutral red counterstaining is visible. In contrast, the liver from a Cp-/- (-/-) mouse shows strong labeling for iron, which appears as blue staining.

Iron homeostasis is disrupted in Cp-/- mice

Because severe hepatic iron accumulation is a hallmark of Cp deficiency in humans, and because the clinical symptoms are generally detected later in life between the ages of 45 and 55 years, we examined the liver of 16-month-old Cp-/- mice for iron content. Abundant iron accumulation was observed within hepatocytes in the liver of Cp-/- mice using the Perl's stain (Fig. 1D). In contrast, very little staining was seen in the liver of Cp+/+ mice (Fig. 1D).

Cp-/- mice were examined for changes in various hematological parameters associated with a lack of Cp. Compared with Cp+/+ mice, Cp-/- mice had a severe reduction in serum iron levels (Table 1). This ~6.5-fold reduction in serum iron levels is also reflected in the lower transferrin saturation (the percentage of total iron binding sites in transferrin loaded with iron) in these mice (4 vs 27%). No significant changes in serum hemoglobin levels (Table 1) or in several other hematological parameters, such as hematocrit or white blood cell count, were observed (data not shown). Using an assay that measures TNHI, iron levels were found to be highly elevated in the liver of Cp-/- mice compared with Cp+/+ controls. Cp-/- mice had a 10.6-fold increase in hepatic TNHI at 16 months (Table 1). Iron levels in the spleen were not statistically significantly different between the two groups of mice.


                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Serum and tissue iron content in wild-type and ceruloplasmin knock-out mice

Iron accumulates in the CNS of Cp-/- mice

Because iron accumulation in the CNS is a characteristic feature of patients with aceruloplasminemia, we examined various regions of the nervous system, including different parts of the brain and spinal cord and the retina, for iron accumulation. The total non-heme iron content of the brainstem and cerebellum was significantly elevated in the Cp-/- mice at 16 months, with the brainstem showing a 103% increase and the cerebellum a 35% increase over Cp+/+ mice (Fig. 2A). The spinal cord was also affected in Cp-/- mice, with the cervical spinal cord demonstrating a 116% increase and the thoracic spinal cord an 84% increase over Cp+/+ mice (Fig. 2A). The retina showed a 93% elevation in iron content in the Cp-/- mice. The levels of iron in other parts of the nervous system, such as the cortex, caudate/putamen, olfactory bulb, and lumbar spinal cord, were not significantly different between Cp-/- and Cp+/+ mice.



View larger version (28K):
[in this window]
[in a new window]
  		Figure 2.   Iron content and lipid peroxidation in CNS. A, The total non-heme iron content of different brain regions from Cp+/+ and Cp-/- mice. Values are shown as the mean ± SE. n = 4 for both groups of mice (*p <=  0.05; Student's t test). B, Levels of lipid peroxidation as assessed by measuring the levels of 2-thiobarbituric acid reactive substances in tissue homogenates of different brain regions from wild-type and knock-out mice are displayed. Values are shown as the mean ± SE. n = 4 for both groups of mice (*p <=  0.05; Student's t test).

Iron deposition in the cerebellum and midbrain was also assessed histochemically using a modified Perl's technique. Marked iron deposition was detected in both regions in 24-month-old Cp-/- mice. The deposits in the cerebellum were prominent in the granule cell layer (Fig. 3A,B) and the deep cerebellar nuclei. Iron staining was also seen in the region of the substantia nigra (data not shown). Iron levels are known to be high in the normal substantia nigra although this iron is bound to protein and therefore not toxic. On the other hand, the iron deposits in Cp-/- mice are likely to be in the redox active state because the viability of these neurons is severely reduced (see below).



View larger version (117K):
[in this window]
[in a new window]
  		Figure 3.   Iron histochemistry and Neurodegeneration. A, B, Iron histochemistry of the cerebellum of Cp+/+ (A) and Cp-/- mice (B). Iron deposits, which appear brown in color (arrows), are seen in the granule cell layer in Cp-/- mice (B). The inset in B shows these iron deposits at higher magnification. Scale bar, 100 µm. C, D, TH+ dopaminergic neurons in the substantia nigra of Cp+/+ (C) and Cp-/- mice (D). There are fewer TH+ neurons in the null mice (D), and those present appear to be undergoing degeneration. Scale bars, 100 µm.

Increased free radical-mediated damage occurs in the CNS of Cp-/- mice

Because the lack of Cp leads to increased iron deposition in some regions of the CNS and because Cp is an antioxidant, we assessed lipid peroxidation in different parts of the CNS as evidence of oxidative damage. Significant elevations in lipid peroxidation were observed in the olfactory bulb (84% increase) and the cervical spinal cord (58% increase) (Fig. 2B) of Cp-/- mice at 16 months. Despite having elevated levels of iron in Cp-/- mice, the cerebellum, brainstem, thoracic spinal cord, and retina did not show significant increases in lipid peroxidation by the assay that was used. It is possible that the gradual accumulation of iron over a period of months may result in a low level of cell damage occurring over a prolonged period of time, which may not be detected by the assay used. This is supported by the findings that despite the lack of an increase in lipid peroxidation products in the brainstem and retina, there was loss of tyrosine hydroxylase-positive dopaminergic neurons in the brainstem (Fig. 3C,D) and histological evidence of neurodegeneration in the inner nuclear layer of the retina (Fig. 4A-D). Ceruloplasmin mRNA has been shown to be expressed mainly in this layer of the retina (Klomp and Gitlin, 1996).



View larger version (123K):
[in this window]
[in a new window]
  		Figure 4.   Retinal degeneration. A, B, Retina of 18-month-old Cp+/+ (A) and Cp-/- mice (B) in Epon-embedded sections stained with toluidine blue. Neurodegenerative changes are seen in the inner nuclear layer (INL) of Cp-/- mice (B). ONL, Outer nuclear layer; GCL, ganglion cell layer. C, D, Higher magnification of the inner nuclear layer of Cp+/+ and Cp-/- mice, respectively. Neurons in this layer in wild-type mice are large rounded cells with a prominent nucleolus (C). In contrast, in Cp-/- mice many of the cells in this layer show condensed chromatin and dark cytoplasmin (D, arrows). Cells with small, irregularly shaped nuclei that are likely to be macrophages are also present in Cp-/- mice (D). Scale bars (shown in B for A, B): 50 µm; (shown in D for C, D): 20 µm.

On the other hand it is also possible that in some CNS regions other antioxidant mechanisms may protect cells from iron-mediated oxidative damage. This possibility is supported by the fact that although massive iron accumulation occurs in the liver of Cp-/- mice, it does not show a significant increase in lipid peroxidation. In addition, although the olfactory bulb did not show a significant increase in iron content in Cp-/- mice, it showed a marked elevation in lipid peroxidation, suggesting that in some CNS regions there may be a change in the redox active state of iron.

Neural cells from Cp-/- mice are more susceptible to free radical injury

Because Cp is an antioxidant and GPI-anchored Cp is expressed by astrocytes, we examined whether neural cells from Cp-/- mice have an increased susceptibility to oxidative stress. Dissociated neonatal cerebellar cell cultures from Cp-/- and Cp+/+ mice were treated with H2O2, and their viability was assessed 24 hr later. Cerebellar cultures from Cp+/+ mice were not affected by 50 µM H2O2. In contrast, cultures from Cp-/- mice showed a 45% reduction in viability compared with untreated cultures using the MTT assay (Fig. 5A). Cell counts showed a 90% loss in viability of Cp-/- cultures (588 ± 17/mm2 untreated; 60 ± 5/mm2 treated) but no loss in cultures of cells from Cp+/+ mice (530 ± 22/mm2 untreated; 533 ± 30/mm2 treated). The more severe effect detected with the cell counts is likely caused by the loss of very weakly attached cells that are lost because of the extra washing steps required to stain the cells for counting. Double-immunofluorescence staining for astrocytes and neurons showed that although the viability of both cell types was reduced in Cp-/- by such treatment, the neuronal loss was more severe (Fig. 6). At the higher (250 µM) concentration of H2O2, cultures from both Cp-/- and Cp+/+ mice displayed a drastic reduction in viability (Fig. 5A). This result suggests that at this high concentration of H2O2, the protection mediated by Cp is insufficient to prevent cellular injury. Alternatively, Cp itself might be damaged by the high H2O2 and would therefore no longer be protective. The latter possibility is supported by the observation that H2O2 at high concentrations leads to the release of redox-active copper atoms within Cp and the fragmentation of the protein (Choi et al., 2000).



View larger version (18K):
[in this window]
[in a new window]
  		Figure 5.   Susceptibility of cerebellar cultures to H2O2 toxicity. A, Cultures of dissociated cerebellum were treated with H2O2, and their viability was assessed using MTT assay. Viability is expressed relative to untreated (0 µM H2O2) control cultures and is shown as the mean ± SE. Results are from three separate experiments. There is a significant decrease in cell viability in cultures of cerebellar cells from Cp-/- mice as compared with those from Cp+/+ mice treated with 50 µM H2O2 (*p <=  0.05; Student's t Test). B, Cultures of dissociated cerebellum were treated with H2O2 in the presence of 125 µM DFO mesylate. Viability was assessed as above and is the result of three separate experiments. DFO treatment eliminated the decrease in viability of the knockout cultures mediated by the 50 µM H2O2 concentration. DFO partially prevented the decrease in viability caused by the 250 µM H2O2 concentration, and it rescued the cultures from Cp+/+ mice to a significantly greater extent (*p <=  0.05; Student's t test).



View larger version (20K):
[in this window]
[in a new window]
  		Figure 6.   Counts of astrocyte and neuronal populations in cerebellar cultures from Cp+/+ and Cp-/- mice treated with 50 µM H2O2 indicate that although the viability of both cell types is reduced in cultures of Cp-/- mice, the loss of neurons is more drastic than that of astrocytes. Results are presented as percentage viability compared with untreated cultures.

The reduction in viability of the cerebellar cultures from Cp-/- mice caused by H2O2 in vitro is likely to be caused by the production of toxic hydroxyl radicals. H2O2 can react with a number of different redox-active metals to generate this free radical (Winterbourn, 1995). To determine whether the toxicity of H2O2 was mediated by iron, cerebellar cultures were treated with H2O2 in the presence of the iron chelator DFO, and cell viability was assessed 24 hr later. DFO completely prevented the decrease in viability of the Cp-/- cultures treated with 50 µM H2O2 (Fig. 5B). The iron chelator only partially prevented the decrease in viability of both the Cp-/- and Cp+/+ cultures treated with 250 µM H2O2. However, the level of rescue was higher in cultures from Cp+/+ control mice compared with those from Cp-/- mice. High concentrations of H2O2 can promote the release of iron from the iron-DFO complex (Borg and Schaich, 1986) and may underlie the partial rescue at the higher H2O2 concentration.

Cp-/- mice have impaired motor coordination

To assess whether the increased accumulation of iron and increased oxidative injury in the CNS of Cp-/- mice affect motor behavior, we performed the rotary rod assay on mice at 16 months. Cp-/- mice had an impaired ability to remain on the rotary rod compared with the Cp+/+ mice. Although the Cp+/+ mice remained on the rotary rod for >3 min, the Cp-/- mice remained on the rod for <25 sec, indicating a severe loss of motor coordination in these mice (Fig. 7). Cp+/+ and Cp-/- mice did not demonstrate statistically significant differences in strength (121 ± 13 vs 103 ± 9 gm) or locomotory endurance (3823 ± 733 vs 6062 ± 2647 m), the latter assessed using the hamster wheel assay. These results suggest that the motor deficit in Cp-/- mice observed using the rotary rod assay was not caused by increased fatigability or decreased strength.



View larger version (16K):
[in this window]
[in a new window]
  		Figure 7.   Tests of motor coordination. Motor coordination of Cp+/+ and Cp-/- mice was assessed using the rotary rod assay. Mice were placed on a rotating rod, and the time, in seconds, that the mice remained on the rod without falling off, up to a maximum of 180 sec, was recorded. Mice of 16 months of age were used. The results are the shown as the mean ± SE; n = 4 for each group. A significant impairment in the ability of Cp-/- mice to remain on the rotary rod compared with Cp+/+ mice is observed (p <=  0.05; Student's t test).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Increased iron accumulation in the CNS of Cp-/- mice

Iron accumulates in different parts of the CNS in Cp-deficient mice to varying extents. The accumulation is high in the brainstem, retina, and cervical and thoracic spinal cord, with approximately a doubling of the iron content. A significant increase in iron is also found in the cerebellum. The iron deposition seen in these mice is similar in some respects to that observed in patients with aceruloplasminemia, because these patients also display iron accumulation in the brainstem, cerebellum, and retina (Miyajima et al., 1987; Harris et al., 1995; Morita et al., 1995; Yoshida et al., 1995). However, other regions such as the caudate and putamen, which show iron accumulation in aceruloplasminemia patients, appeared to have normal iron levels in Cp null mice. Overall, the extent of iron accumulation in the CNS of Cp-/- mice appears to be less than that observed in patients with aceruloplasminemia, because in the latter the iron accumulation is observable at the gross anatomical level in autopsy samples of the brain (Morita et al., 1995). In humans, neurological symptoms are manifested only between the age of 45 and 55 years (Miyajima et al., 1987; Morita et al., 1995; Yoshida et al., 1995), indicating that severe iron accumulation in the CNS takes several decades. The shorter life span of mice may account for the lower levels of iron accumulation in Cp-/- mice.

The iron accumulation in some regions of the CNS of Cp-/-mutant mice, such as the cerebellum and brainstem, may contribute to the deficit in motor coordination observed using the rotary rod assay. This motor deficiency is somewhat similar to the behavioral deficits observed in patients with aceruloplasminemia (Yoshida et al., 1995; Okamoto et al., 1996). Although an increase in lipid peroxidation was not observed in the cerebellum of Cp-/- mice, the in vitro experiments indicate that cerebellar cells are susceptible to iron-mediated oxidative stress. Iron does not accumulate in tissues such as muscle or kidney of Cp-/- mice (data not shown), indicating that iron accumulation is not a generalized nonspecific phenomenon. In addition, iron accumulation in the CNS of Cp-/- mice is not caused by high serum load, because serum iron is markedly decreased.

Cp prevents oxidative damage in the CNS

Because the increase in iron in the CNS might lead to increased oxidative stress caused by the reaction of ferrous iron with oxygen and endogenously produced peroxides, we looked for signs of increased oxidative injury in Cp-/- mice. Surprisingly, significantly elevated levels of lipid peroxidation were seen only in the olfactory bulb and the cervical spinal cord. Although the increased lipid peroxidation in the cervical spinal cord was associated with an accumulation of iron, the olfactory bulb did not show an increase in iron. Because Cp is a ferroxidase that oxidizes highly toxic ferrous [Fe (II)] iron to the ferric [Fe (III)] form, it is a potent antioxidant. Therefore, the increased lipid peroxidation observed in the olfactory bulb may be attributable to an increase in the ratio of Fe (II)/Fe (III), caused by the absence of the ferroxidase activity of Cp, rather than to an increase in the quantity of iron.

Despite showing iron accumulation, the cerebellum, brainstem, thoracic spinal cord, and retina did not display a significant elevation in lipid peroxidation. This may be attributable to regional differences in the capacity to manage iron and oxidative stress. For example, different regions of the CNS vary in their susceptibility to iron-dependent lipid peroxidation and in their antioxidant potential (Hussain et al., 1995; Surai et al., 1999). In addition, different regions of the CNS also vary in the expression of ferritin and thus may differ in their capacity to bind iron and render it nontoxic (Han et al., 2000). On the other hand, the gradual accumulation of iron over months may result in a low level of cell and tissue damage over a prolonged period that may be difficult to detect by measuring lipid peroxidation products. This is supported by the evidence of neurodegeneration of dopaminergic neurons in the substantia nigra in the brainstem and of neurons in the inner nuclear layer of the retina. Interestingly, in the retina, ceruloplasmin mRNA expression is detected mainly in the inner nuclear layer (Klomp and Gitlin, 1996).

That Cp is an effective antioxidant in vivo is supported by the in vitro experiments using neonatal cerebellar cultures. These cultures contain astrocytes that express Cp in vivo (Klomp and Gitlin, 1996; Klomp et al., 1996) and in vitro (Zahs et al., 1993; Patel and David, 1997). We have shown previously that GPI-anchored Cp, which is expressed by astrocytes, is the predominant form of this protein expressed in the CNS (Patel et al., 2000). Cerebellar cultures from Cp-/- mice were susceptible to 50 µM H2O2, demonstrating a significant decrease in viability. In contrast, Cp+/+ cultures were unaffected, indicating that Cp protects these cells from free radical injury. The decrease in viability of cerebellar cultures from Cp-/- mice mediated by 50 µM H2O2 could be completely prevented by DFO, a cell-permeable iron chelator. These data indicate that the H2O2 toxicity is mediated by iron, most likely involving the production of highly toxic hydroxyl radicals via the Fenton reaction (Borg and Schaich, 1986).

Role of Cp in vivo

Our data on Cp-/- mice support the earlier findings by Harris et al. (1999) indicating that Cp is essential for iron homeostasis in non-neural tissues. In addition, we show that Cp plays a similar role in the CNS. Cp likely plays an important role in loading iron onto transferrin, and this helps mobilize iron out of hepatocytes. This is supported by the observation that Cp enhances the efflux of iron out of hepatocyte cell lines in combination with transferrin in vitro (Young et al., 1997; Richardson, 1999). Furthermore, Harris et al. (1999) reported recently that Cp administered to Cp knock-out mice can mobilize iron out of the liver and temporarily restore normal iron homeostasis. As expected, we observed a marked reduction in serum iron in our Cp-/- mice that is similar to that seen in patients with aceruloplasminemia. However, Harris et al. (1999) did not observe any differences in serum iron in their Cp-/- and Cp+/+ mice. Differences in the mouse strains (C57BL/6J and black Swiss-Webster) may underlie the observed differences in serum iron levels, but the mechanism whereby the mice of Harris et al. (1999) are able to maintain apparently normal serum iron levels is not known. Although there are differences in the gene targeting strategies that were used in the two studies, ceruloplasmin could not be detected by Western blotting in the serum of either type of Cp-/- mice.

How Cp prevents iron accumulation in the CNS is not known. Iron uptake by the brain appears to be mediated primarily by transferrin receptors located on the brain capillary endothelial cells (Malecki et al., 1999) as well as on certain neural cells (Roskams and Connor, 1992). Other non-transferrin-mediated iron uptake mechanisms may also exist, such as via the iron transporter DMT1 (Williams et al., 2000). GPI-Cp could play a role in limiting the amount of ferrous iron available for transport via DMT1, which has specificity for ferrous iron (Andrews, 1999). The efflux of iron out of CNS cells may occur via transporters such as Ireg1/ferroportin1, a membrane protein that has been shown to transport ferrous iron out of intestinal epithelial cells (Donovan et al., 2000; McKie et al., 2000). GPI-ceruloplasmin in the brain could also potentially play a role in controlling the efflux of ferrous iron via Ireg1 by rapidly oxidizing it to the ferric form as it exits at the cell surface. Such a mechanism may prevent iron accumulation in the normal CNS and lead to accumulation in the Cp-null mice and in humans with aceruloplasminemia. Hephaestin, an integral membrane protein with ferroxidase activity that is found in intestinal epithelial cells, has homology to Cp and appears to mediate iron efflux from gut epithelial cells (Vulpe et al., 1999; Frazer et al., 2001). Mice lacking hephaestin accumulate iron in the gut caused by impaired egress of iron from intestinal enterocytes (Vulpe et al., 1999). In the CNS, GPI-anchored Cp, which is expressed on the surface of astrocytes, could play a similar role in the efflux of iron out of the CNS.


    CONCLUSIONS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Our data indicate that Cp is an effective antioxidant in the CNS in vivo and protects neural cells from oxidative stress. The antioxidant function of Cp is likely to be particularly crucial during CNS injury, such as ischemia or mechanical trauma, when levels of free iron and reactive oxygen species, including H2O2, increase (Hyslop et al., 1995; Palmer et al., 1999). During such injuries, the levels of Cp are also likely to increase because Cp is an acute-phase protein. Indeed, levels of Cp increase in the retina after optic nerve crush (Levin and Geszvain, 1998).

The pathological changes observed in patients with aceruloplasminemia and in Cp-/- mice share similarities with other neurodegenerative diseases. Iron accumulation occurs in the substantia nigra in Parkinson's disease, in the cortex and amyloid plaques in Alzheimer's disease, and in the spinal cord in amyotrophic lateral sclerosis (Gerlach et al., 1994). In addition, levels of free radicals and markers of oxidative injury are also elevated in these disorders (Olanow, 1993; Boll et al., 1999). Whether a reduction in Cp levels contributes to the pathology of these neurodegenerative diseases is not yet known. However, levels of Cp are reduced in the cortex in Alzheimer's disease (Connor et al., 1993), and the ferroxidase activity of Cp is reduced in the cerebrospinal fluid in Parkinson's disease (Boll et al., 1999). It is therefore possible that a reduction in Cp may contribute to the neurodegenerative process in these disorders by leading to an increase in the levels of ferrous iron, which can promote the generation of toxic free radicals. Thus, in addition to providing insights into the human disease aceruloplasminemia, Cp-/- mice could also serve as a useful model to study the role of Cp in the more common neurodegenerative diseases. Furthermore, these mice could potentially be used to test novel therapeutic strategies to prevent iron-mediated free radical injury in the CNS.


    FOOTNOTES

Received Jan. 11, 2002; revised May 7, 2002; accepted May 9, 2002.

This work was supported by a grant from the Canadian Institutes of Health Research and the Parkinson's Disease Foundation (S.D.). B.N.P. was supported by studentships from the National Centers of Excellence NeuroScience Network and the David and Dorothy Lam Award from the NeuroScience Canada Foundation.

Correspondence should be addressed to Dr. Samuel David, Centre for Research in Neuroscience, Montreal General Hospital Research Institute, 1650 Cedar Avenue, Montreal, Quebec, Canada H3G 1A4. E-mail: sdavid11{at}po-box.mcgill.ca.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

  • Andrews NC (1999) The iron transporter DMT1. Int J Biochem Cell Biol 31:991-994[Web of Science][Medline].
  • Boll M-C, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C (1999) Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci Lett 265:155-158[Medline].
  • Borg DC, Schaich KM (1986) Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine. J Free Radic Biol Med 2:237-243[Medline].
  • Bowie AG, Moynagh PN, O'Neill LAJ (1997) Lipid peroxidation is involved in the activation of NF-kappaB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. J Biol Chem 272:25941-25950[Abstract/Free Full Text].
  • Choi SY, Kwon HY, Kwon OB, Eum WS, Kang JH (2000) Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie 82:175-180[Medline].
  • Connor JR, Tucker P, Johnson M, Snyder B (1993) Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett 159:88-90[Web of Science][Medline].
  • De Silva DM, Askwith CC, Kaplan J (1996) Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev 76:31-47[Abstract/Free Full Text].
  • Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:776-781[Medline].
  • Fleming RE, Gitlin JD (1990) Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J Biol Chem 265:7701-7707[Abstract/Free Full Text].
  • Frazer DM, Vulpe CD, McKie AT, Wilkins SJ, Trinder D, Cleghorn GJ, Anderson GJ (2001) Cloning and gastrointestinal expression of rat hephaestin: relationship to other iron transport proteins. Am J Physiol Gastrointest Liver Physiol 281:G931-G939[Abstract/Free Full Text].
  • Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20:2534-2542[Abstract/Free Full Text].
  • Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63:793-807[Web of Science][Medline].
  • Gitlin JD (1998) Aceruloplasminemia. Pediatr Res 44:271-276[Web of Science][Medline].
  • Gutteridge JM (1992) Iron and oxygen radicals in brain. Ann Neurol 32:S16-S21.
  • Han J, Day JR, Thomson K, Connor JR, Beard JL (2000) Iron deficiency alters H- and L-ferritin expression in rat brain. Cell Mol Biol 46:517-528[Medline].
  • Hansen MB, Nielsen SE, Berg K (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210[Web of Science][Medline].
  • Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivary RT, Gitlin JD (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539-2543[Abstract/Free Full Text].
  • Harris ZL, Durley AP, Man TK, Gitlin JD (1999) Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96:10812-10817[Abstract/Free Full Text].
  • Hellman NE, Kono S, Miyajima H, Gitlin JD (2002) Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem 277:1375-1380[Abstract/Free Full Text].
  • Hussain S, Slikker Jr W, Ali SF (1995) Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain. Int J Dev Neurosci 13:811-817[Web of Science][Medline].
  • Hyslop PA, Zhang Z, Pearson DV, Phebus LA (1995) Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res 671:181-186[Web of Science][Medline].
  • Joyner AL (1993) In: Gene targeting: a practical approach. Oxford: Oxford UP.
  • Klomp LW, Gitlin JD (1996) Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 5:1989-1996[Abstract/Free Full Text].
  • Klomp LW, Farhangrazi ZD, Dugan LL, Gitlin JD (1996) Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 98:207-215[Web of Science][Medline].
  • Levin LA, Geszvain KM (1998) Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest Ophthalmol Vis Sci 39:157-163[Abstract/Free Full Text].
  • Liu C, Weaver DR, Strogatz SH, Reppert SM (1997) Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell 91:855-860[Web of Science][Medline].
  • Malecki EA, Devenyi AG, Beard JL, Connor JR (1999) Existing and emerging mechanisms for transport of iron and manganese to the brain. Neurosci Res 56:113-122.
  • McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299-309[Web of Science][Medline].
  • Mittal B, David S (1994) A monoclonal antibody that recognizes an adhesion molecule expressed by certain cells of neuroectodermal and mesenchymal origin. Mol Cell Neurosci 5:63-77[Medline].
  • Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767[Abstract/Free Full Text].
  • Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S, Kato M, Yanagisawa N (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 37:646-656[Web of Science][Medline].
  • Okamoto N, Wada S, Oga T, Kawabata Y, Baba Y, Habu D, Takeda Z, Wada Y (1996) Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet 97:755-758[Web of Science][Medline].
  • Olanow CW (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444[Web of Science][Medline].
  • Osaki S, Johnson DA, Frieden E (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 241:2746-2751[Abstract/Free Full Text].
  • Ousman S, David S (2000) Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92-104[Web of Science][Medline].
  • Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor JR (1999) Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 56:60-71[Web of Science][Medline].
  • Patel BN, David S (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272:20185-20190[Abstract/Free Full Text].
  • Patel BN, Dunn RJ, David S (2000) Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 275:4305-4310[Abstract/Free Full Text].
  • Richardson DR (1999) Role of ceruloplasmin and ascorbate in cellular iron release. J Lab Clin Med 134:454-465[Medline].
  • Roskams AJ, Connor JR (1992) Transferrin receptor expression in myelin deficient (md) rats. J Neurosci Res 31:421-427[Web of Science][Medline].
  • Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94:9866-9868[Abstract/Free Full Text].
  • Steele PM, Medina JF, Nores WL, Mauk MD (1998) Using genetic mutations to study the neural basis of behavior. Cell 95:879-882[Web of Science][Medline].
  • Surai PF, Speake BK, Noble RC, Sparks NH (1999) Tissue-specific antioxidant profiles and susceptibility to lipid peroxidation of the newly hatched chick. Biol Trace Elem Res 68:63-78[Web of Science][Medline].
  • Torrance JD, Bothwell TH (1980) Tissue iron stores. In: Methods in hematology: iron (Cook JD, ed), pp 90-115. New York: Churchill Livingstone.
  • Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier, Anderson GJ (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21:195-199[Web of Science][Medline].
  • Williams K, Wilson MA, Bressler J (2000) Regulation and developmental expression of the divalent metal-iron transporter in the rat brain. Cell Mol Biol 46:563-571[Web of Science][Medline].
  • Winterbourn CC (1995) Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett 82-83:969-974[Medline].
  • Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, Hiyamuta S, Ikeda S, Shimizu N, Yanagisawa N (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9:267-272[Web of Science][Medline].
  • Young SP, Fahmy M, Golding S (1997) Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells. FEBS Lett 411:93-96[Web of Science][Medline].
  • Zahs KR, Bigornia V, Deschepper CF (1993) Characterization of "plasma proteins" secreted by cultured rat macroglial cells. Glia 7:121-133[Medline].

Copyright © 2002 Society for Neuroscience  0270-6474/02/22156578-09$05.00/0


This article has been cited by other articles:


Home page
 StrokeHome page
C. Altamura, R. Squitti, P. Pasqualetti, C. Gaudino, P. Palazzo, F. Tibuzzi, D. Lupoi, M. Cortesi, P. M. Rossini, and F. Vernieri
Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke
Stroke, April 1, 2009; 40(4): 1282 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Tapryal, C. Mukhopadhyay, D. Das, P. L. Fox, and C. K. Mukhopadhyay
Reactive Oxygen Species Regulate Ceruloplasmin by a Novel mRNA Decay Mechanism Involving Its 3'-Untranslated Region: IMPLICATIONS IN NEURODEGENERATIVE DISEASES
J. Biol. Chem., January 16, 2009; 284(3): 1873 - 1883.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
T. Jursa and D. R. Smith
Ceruloplasmin Alters the Tissue Disposition and Neurotoxicity of Manganese, but not its Loading onto Transferrin
Toxicol. Sci., January 1, 2009; 107(1): 182 - 193.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. I. Rathore, B. J. Kerr, A. Redensek, R. Lopez-Vales, S. Y. Jeong, P. Ponka, and S. David
Ceruloplasmin Protects Injured Spinal Cord from Iron-Mediated Oxidative Damage
J. Neurosci., November 26, 2008; 28(48): 12736 - 12747.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. P. Luttrell, M. Swee, B. Starcher, W. C. Parks, and K. Chitaley
Erectile dysfunction in the type II diabetic db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2204 - H2211.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. C. Jones, J. L. Beard, J. N. Gibson, E. L. Unger, R. P. Allen, K. A. McCarthy, and C. J. Earley
Systems genetic analysis of peripheral iron parameters in the mouse
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R116 - R124.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. S. Stoj, A. J. Augustine, E. I. Solomon, and D. J. Kosman
Structure-Function Analysis of the Cuprous Oxidase Activity in Fet3p from Saccharomyces cerevisiae
J. Biol. Chem., March 16, 2007; 282(11): 7862 - 7868.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Stasi, D. Nagel, X. Yang, L. Ren, T. Mittag, and J. Danias
Ceruloplasmin Upregulation in Retina of Murine and Human Glaucomatous Eyes
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 727 - 732.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. L. Dunaief
Iron Induced Oxidative Damage As a Potential Factor in Age-Related Macular Degeneration: The Cogan Lecture
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4660 - 4664.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Y. Jeong and S. David
Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice.
J. Neurosci., September 20, 2006; 26(38): 9810 - 9819.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. E. Wiggins, M. Goyal, B. L. Wharram, and R. C. Wiggins
Antioxidant Ceruloplasmin Is Expressed by Glomerular Parietal Epithelial Cells and Secreted into Urine in Association with Glomerular Aging and High-Calorie Diet
J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1382 - 1387.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Galy, D. Ferring, B. Minana, O. Bell, H. G. Janser, M. Muckenthaler, K. Schumann, and M. W. Hentze
Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2)
Blood, October 1, 2005; 106(7): 2580 - 2589.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Barnes, R. Tsivkovskii, N. Tsivkovskaia, and S. Lutsenko
The Copper-transporting ATPases, Menkes and Wilson Disease Proteins, Have Distinct Roles in Adult and Developing Cerebellum
J. Biol. Chem., March 11, 2005; 280(10): 9640 - 9645.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
H. Hochstrasser, P. Bauer, U. Walter, S. Behnke, J. Spiegel, I. Csoti, B. Zeiler, A. Bornemann, J. Pahnke, G. Becker, et al.
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease
Neurology, November 23, 2004; 63(10): 1912 - 1917.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. D. Dunning, A. Lakatos, L. Loizou, M. Kettunen, C. ffrench-Constant, K. M. Brindle, and R. J. M. Franklin
Superparamagnetic Iron Oxide-Labeled Schwann Cells and Olfactory Ensheathing Cells Can Be Traced In Vivo by Magnetic Resonance Imaging and Retain Functional Properties after Transplantation into the CNS
J. Neurosci., November 3, 2004; 24(44): 9799 - 9810.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Hahn, Y. Qian, T. Dentchev, L. Chen, J. Beard, Z. L. Harris, and J. L. Dunaief
Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration
PNAS, September 21, 2004; 101(38): 13850 - 13855.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Zecca, A. Stroppolo, A. Gatti, D. Tampellini, M. Toscani, M. Gallorini, G. Giaveri, P. Arosio, P. Santambrogio, R. G. Fariello, et al.
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
PNAS, June 29, 2004; 101(26): 9843 - 9848.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. H. Farkas, I. Chowers, A. S. Hackam, M. Kageyama, R. W. Nickells, D. C. Otteson, E. J. Duh, C. Wang, D. F. Valenta, T. L. Gunatilaka, et al.
Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1410 - 1417.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Mani, F. Cheng, B. Havsmark, S. David, and L.-A. Fransson
Involvement of Glycosylphosphatidylinositol-linked Ceruloplasmin in the Copper/Zinc-Nitric Oxide-dependent Degradation of Glypican-1 Heparan Sulfate in Rat C6 Glioma Cells
J. Biol. Chem., March 26, 2004; 279(13): 12918 - 12923.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. M. Lee, H.-W. Lo, R.-P. Shao, S.-C. Wang, W. Xia, D. M. Gershenson, and M.-C. Hung
Selective Activation of Ceruloplasmin Promoter in Ovarian Tumors: Potential Use for Gene Therapy
Cancer Res., March 1, 2004; 64(5): 1788 - 1793.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Y. Jeong and S. David
Glycosylphosphatidylinositol-anchored Ceruloplasmin Is Required for Iron Efflux from Cells in the Central Nervous System
J. Biol. Chem., July 11, 2003; 278(29): 27144 - 27148.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. F. Chang, R. J. Wong, H. J. Vreman, T. Igarashi, E. Galo, F. R. Sharp, D. K. Stevenson, and L. J. Noble-Haeusslein
Heme Oxygenase-2 Protects against Lipid Peroxidation-Mediated Cell Loss and Impaired Motor Recovery after Traumatic Brain Injury
J. Neurosci., May 1, 2003; 23(9): 3689 - 3696.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, B. N.
Right arrow Articles by David, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, B. N.
Right arrow Articles by David, S.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-